Brief: AIM Vaccine Says Fully Integrates Deepseek In All Business Scenarios
23/02/2025 11:26
Feb 23 (Reuters) - AIM Vaccine Co Ltd 6660.HK :
* SAYS CO FULLY INTEGRATES DEEPSEEK IN ALL BUSINESS
SCENARIOS,
COVERING RESEARCH AND DEVELOPMENT, PRODUCTION, SALES
Source text
Further company coverage: 6660.HK
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on AIM Vaccine
See all newsBrief: AIM Vaccine Co Submits Application For Human Diploid Cell Rabies Vaccine In China
Brief: AIM Vaccine Says Tibet Bohai To Subscribe 37.4 Million Shares At RMB1.07 Each
Brief: AIM Vaccine Approves Issuance Of Up To 40 Million Domestic Shares
Brief: Aim Vaccine Says Serum-Free Rabies Vaccine Passes Inspection
Brief: AIM Vaccine Updates On 20-Valent Pneumococcal Polysaccharide Conjugate Vaccine